(Q39240059)

10 September 2017

title

Occurrence and modulation of therapeutic targets of Aurora kinase inhibition in pediatric acute leukemia cells (English)

1 reference

10 September 2017

1 reference

1 reference

Aarthi Jayanthan

1

1 reference

10 September 2017

Todd M Cooper

2

1 reference

10 September 2017

Kimberley A Hoeksema

3

1 reference

10 September 2017

Shamim Lotfi

4

1 reference

10 September 2017

Evan Woldum

5

1 reference

10 September 2017

Victor A Lewis

6

1 reference

10 September 2017

Aru Narendran

7

1 reference

10 September 2017

publication date

29 December 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

54

1 reference

10 September 2017

issue

7

1 reference

10 September 2017

page(s)

1505-1516

1 reference

New therapeutic strategies for the treatment of acute lymphoblastic leukaemia

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Treatment of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

New therapeutic strategies in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Relapsed acute lymphoblastic leukemia: current status and future opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Acute lymphoblastic leukemia in infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The cellular geography of aurora kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The expression of the aurora-A gene and its significance with tumorgenesis in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora-B dysfunction of multinucleated giant cells in glioma detected by site-specific phosphorylated antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora kinases as anticancer drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora-C kinase supports mitotic progression in the absence of Aurora-B

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The Aurora kinases: role in cell transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Discovery and development of aurora kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Aurora kinase inhibitors: novel small molecules with promising activity in acute myeloid and Philadelphia-positive leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Effects of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on pediatric acute lymphoblastic leukemia (ALL) with respect to Bcr-Abl status and imatinib mesylate sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Recombinant tumor necrosis factor alpha and interleukin 1 alpha increase expression of c-abl protooncogene mRNA in cultured human marrow stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The role of FLT3 in haematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

FLT3: ITDoes matter in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The Myc oncoprotein as a therapeutic target for human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Identification of aneuploidy-selective antiproliferation compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Hsp90 activation and cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

A new acute lymphoblastic leukaemia cell line BEL-1 with t(4; 11) (q21; q23) chromosomal translocation and a unique aberrant p27 transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2012.752079

10.3109/10428194.2012.752079

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference